{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:43:20Z","timestamp":1788385400288,"version":"build-2803163510"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113816","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T04:01:04Z","timestamp":1734667264000},"page":"113816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Traumatic brain Injury: Comprehensive overview from pathophysiology to Mesenchymal stem Cell-Based therapies"],"prefix":"10.1016","volume":"146","author":[{"given":"Mahsa","family":"Hajivalili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Nikkhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvenaz","family":"Salahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2357-0690","authenticated-orcid":false,"given":"Maryam","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2024.113816_b0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1515\/revneuro-2019-0002","article-title":"Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects","volume":"30","author":"Das","year":"2019","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.intimp.2024.113816_b0010","doi-asserted-by":"crossref","unstructured":"Taylor, C.A., Traumatic brain injury\u2013related emergency department visits, hospitalizations, and deaths\u2014United States, 2007 and 2013. MMWR. Surveillance Summaries, 2017. 66.","DOI":"10.15585\/mmwr.ss6609a1"},{"issue":"5","key":"10.1016\/j.intimp.2024.113816_b0015","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.injury.2021.01.042","article-title":"Predictors of traumatic brain injury morbidity and mortality: examination of data from the national trauma data bank: predictors of TBI morbidity & mortality","volume":"52","author":"Miller","year":"2021","journal-title":"Injury"},{"issue":"4","key":"10.1016\/j.intimp.2024.113816_b0020","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3171\/2017.11.JNS171500","article-title":"Global neurosurgery: the current capacity and deficit in the provision of essential neurosurgical care. Executive Summary of the Global Neurosurgery Initiative at the Program in Global Surgery and Social Change","volume":"130","author":"Dewan","year":"2018","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.intimp.2024.113816_b0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1474-4422(18)30415-0","article-title":"Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Injury","year":"2019","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.intimp.2024.113816_b0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/biomedicines8100389","article-title":"Revisiting traumatic brain injury: from molecular mechanisms to therapeutic interventions","volume":"8","author":"Jarrahi","year":"2020","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.intimp.2024.113816_b0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","article-title":"Moderate and severe traumatic brain injury in adults","volume":"7","author":"Maas","year":"2008","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/j.intimp.2024.113816_b0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/AIA.0b013e318078cfe7","article-title":"Traumatic brain injury","volume":"45","author":"Parikh","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"key":"10.1016\/j.intimp.2024.113816_b0045","article-title":"Greenfield's neuropathology","author":"Graham","year":"1997","journal-title":"(no Title)"},{"issue":"6","key":"10.1016\/j.intimp.2024.113816_b0050","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1227\/01.NEU.0000186013.63046.6B","article-title":"Prediction of outcome in traumatic brain injury with computed tomographic characteristics: a comparison between the computed tomographic classification and combinations of computed tomographic predictors","volume":"57","author":"Maas","year":"2005","journal-title":"Neurosurgery"},{"issue":"7","key":"10.1016\/j.intimp.2024.113816_b0055","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/neu.2008.0586","article-title":"Classification of traumatic brain injury for targeted therapies","volume":"25","author":"Saatman","year":"2008","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2024.113816_b0060","doi-asserted-by":"crossref","unstructured":"Ortega Gonz\u00e1lez, F., et al., Molecular Mechanisms of Acute Brain Injury and Ensuing Neurodegeneration. Cap\u00edtol del llibre: Brain Damage-Bridging Between Basic Research and Clinics. Edited by Alina Gonz\u00e1lez-Quevedo, ISBN 978-953-51-0375-2, Hard cover, 282 pages, Publisher: InTech, Published: March 16, 2012 under CC BY 3.0 license. DOI: 10.5772\/2174., 2012.","DOI":"10.5772\/2174"},{"issue":"3","key":"10.1016\/j.intimp.2024.113816_b0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00024382-200116030-00001","article-title":"Role of cerebral inflammation after traumatic brain injury: a revisited concept","volume":"16","author":"Morganti-Kossmann","year":"2001","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.intimp.2024.113816_b0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1460-9568.2009.06820.x","article-title":"Neutralization of interleukin\u20101\u03b2 modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice","volume":"30","author":"Clausen","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.intimp.2024.113816_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114199","article-title":"Mesenchymal stromal cell secretome for traumatic brain injury: Focus on immunomodulatory action","volume":"357","author":"Pischiutta","year":"2022","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2024.113816_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1173-x","article-title":"Neutrophils in traumatic brain injury (TBI): friend or foe?","volume":"15","author":"Liu","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.intimp.2024.113816_b0085","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tins.2020.12.004","article-title":"Bidirectional brain-systemic interactions and outcomes after TBI","volume":"44","author":"Faden","year":"2021","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113816_b0090","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3390\/ijms19041188","article-title":"Sympathetic nerve hyperactivity in the spleen: causal for nonpathogenic-driven chronic immune-mediated inflammatory diseases (IMIDs)?","volume":"19","author":"Bellinger","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113816_b0095","doi-asserted-by":"crossref","unstructured":"Liao, Y., et al., Correction: Oxidative burst of circulating neutrophils following traumatic brain injury in human. PLoS One, 2013. 8(9).","DOI":"10.1371\/annotation\/73ce45d3-4478-4c06-a4d2-3274b6222bae"},{"key":"10.1016\/j.intimp.2024.113816_b0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fneur.2015.00235","article-title":"Traumatic brain injury and peripheral immune suppression: primer and prospectus","volume":"6","author":"Hazeldine","year":"2015","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113816_b0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-3083.2010.02407.x","article-title":"Early Changes in Frequency of Peripheral Blood Lymphocyte Subpopulations in Severe Traumatic Brain\u2010Injured Patients","volume":"72","author":"Mrakovcic-Sutic","year":"2010","journal-title":"Scand. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113816_b0110","first-page":"144","article-title":"Immune system status in the patients after severe brain injury","volume":"106","author":"Smrcka","year":"2005","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.intimp.2024.113816_b0115","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04790","article-title":"Death following traumatic brain injury in Drosophila is associated with intestinal barrier dysfunction","volume":"4","author":"Katzenberger","year":"2015","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.intimp.2024.113816_b0120","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1097\/CCM.0000000000004273","article-title":"Early or late bacterial lung infection increases mortality after traumatic brain injury in male mice and chronically impairs monocyte innate immune function","volume":"48","author":"Doran","year":"2020","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113816_b0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41467-019-08328-5","article-title":"Sympathetic nervous system controls resolution of inflammation via regulation of repulsive guidance molecule A","volume":"10","author":"K\u00f6rner","year":"2019","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2024.113816_b0130","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20132103","article-title":"Vagus nerve controls resolution and pro-resolving mediators of inflammation","volume":"211","author":"Mirakaj","year":"2014","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.113816_b0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/bc.bc_18_17","article-title":"Neuroinflammation in traumatic brain injury: a chronic response to an acute injury","volume":"3","author":"Schimmel","year":"2017","journal-title":"Brain Circulation"},{"issue":"1","key":"10.1016\/j.intimp.2024.113816_b0140","article-title":"Rehabilitation treatment and progress of traumatic brain injury dysfunction","volume":"2017","author":"Dang","year":"2017","journal-title":"Neural Plast."},{"issue":"2","key":"10.1016\/j.intimp.2024.113816_b0145","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3171\/2013.9.JNS13581","article-title":"Surgical management of traumatic brain injury: a comparative-effectiveness study of 2 centers","volume":"120","author":"Hartings","year":"2014","journal-title":"J. Neurosurg."},{"issue":"7","key":"10.1016\/j.intimp.2024.113816_b0150","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/ph15070838","article-title":"Current and potential pharmacologic therapies for traumatic brain injury","volume":"15","author":"Tani","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.intimp.2024.113816_b0155","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ajem.2014.09.023","article-title":"Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis","volume":"32","author":"Zehtabchi","year":"2014","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.intimp.2024.113816_b0160","article-title":"Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury","volume":"12","author":"Bennett","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2024.113816_b0165","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fncel.2019.00528","article-title":"Traumatic brain injuries: pathophysiology and potential therapeutic targets","volume":"13","author":"Ng","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"10012","key":"10.1016\/j.intimp.2024.113816_b0170","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/S0140-6736(15)00386-4","article-title":"Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial","volume":"386","author":"Nichol","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.intimp.2024.113816_b0175","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.4049\/jimmunol.166.12.7527","article-title":"Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia","volume":"166","author":"Tikka","year":"2001","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113816_b0180","first-page":"1257","article-title":"Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis","volume":"111","author":"Jobe","year":"2008","journal-title":"Blood, the Journal of the American Society of Hematology"},{"issue":"1","key":"10.1016\/j.intimp.2024.113816_b0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1474-4422(05)70253-2","article-title":"Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial","volume":"5","author":"Maas","year":"2006","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/j.intimp.2024.113816_b0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3171\/jns.1992.76.1.0013","article-title":"The neuroprotective pharmacology of methylprednisolone","volume":"76","author":"Hall","year":"1992","journal-title":"J. Neurosurg."},{"issue":"5","key":"10.1016\/j.intimp.2024.113816_b0195","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3109\/02688697.2010.487126","article-title":"Local administration of chitosan microspheres after traumatic brain injury in rats: a new challenge for cyclosporine\u2013a delivery","volume":"24","author":"Turkoglu","year":"2010","journal-title":"Br. J. Neurosurg."},{"issue":"1","key":"10.1016\/j.intimp.2024.113816_b0200","article-title":"Mesenchymal stem cell therapy: a potential treatment targeting pathological manifestations of traumatic brain injury","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.intimp.2024.113816_b0205","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002944","article-title":"Mesenchymal stem cells for neurological disorders","volume":"8","author":"Andrzejewska","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.intimp.2024.113816_b0210","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3389\/fimmu.2018.02837","article-title":"Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning","volume":"9","author":"Ferreira","year":"2018","journal-title":"Front. Immunol."},{"issue":"5411","key":"10.1016\/j.intimp.2024.113816_b0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.intimp.2024.113816_b0220","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7150\/ijbs.6.465","article-title":"Skeletal muscle stem cells from animals I. Basic cell biology","volume":"6","author":"Dodson","year":"2010","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.113816_b0225","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng."},{"issue":"12","key":"10.1016\/j.intimp.2024.113816_b0230","first-page":"1421","article-title":"Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation","volume":"89","author":"Villaron","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.intimp.2024.113816_b0235","doi-asserted-by":"crossref","unstructured":"Sanchez, N. and M. Sanz, Periodontal bioengineering with mesenchymal stem cells. Plastic and Aesthetic Research, 2021. 8: p. N\/A-N\/A.","DOI":"10.20517\/2347-9264.2021.26"},{"key":"10.1016\/j.intimp.2024.113816_b0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuroscience.2018.12.005","article-title":"Effects of different doses of mesenchymal stem cells on functional recovery after compressive spinal-cord injury in mice","volume":"400","author":"dos Santos Ramalho","year":"2019","journal-title":"Neuroscience"},{"issue":"13","key":"10.1016\/j.intimp.2024.113816_b0245","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.3390\/jcm10132925","article-title":"Biodistribution of mesenchymal stromal cells after administration in animal models and humans: a systematic review","volume":"10","author":"Sanchez-Diaz","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2024.113816_b0250","doi-asserted-by":"crossref","DOI":"10.1177\/09636897211035715","article-title":"Mesenchymal stem cell-induced anti-neuroinflammation against traumatic brain injury","volume":"30","author":"Cozene","year":"2021","journal-title":"Cell Transplant."},{"issue":"6","key":"10.1016\/j.intimp.2024.113816_b0255","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.yjmcc.2008.03.010","article-title":"Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells","volume":"44","author":"Steingen","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113816_b0260","doi-asserted-by":"crossref","first-page":"e2934","DOI":"10.1371\/journal.pone.0002934","article-title":"Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human","volume":"3","author":"Chamberlain","year":"2008","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.intimp.2024.113816_b0265","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1634\/stemcells.2007-0054","article-title":"The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities","volume":"25","author":"Ponte","year":"2007","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.intimp.2024.113816_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025663","article-title":"Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shear","volume":"6","author":"Chamberlain","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.intimp.2024.113816_b0275","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3324\/haematol.10475","article-title":"Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3","volume":"92","author":"De Becker","year":"2007","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.intimp.2024.113816_b0280","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.3390\/ijms21114051","article-title":"Genetically modified mesenchymal stem cells: the next generation of stem cell-based therapy for TBI","volume":"21","author":"Shahror","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113816_b0285","doi-asserted-by":"crossref","unstructured":"Menge, T., et al., Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury. Science translational medicine, 2012. 4(161): p. 161ra150-161ra150.","DOI":"10.1126\/scitranslmed.3004660"},{"issue":"4","key":"10.1016\/j.intimp.2024.113816_b0290","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.intimp.2024.113816_b0295","first-page":"3722","article-title":"Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide","volume":"101","author":"Krampera","year":"2003","journal-title":"Blood, the Journal of the American Society of Hematology"},{"issue":"3","key":"10.1016\/j.intimp.2024.113816_b0300","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/stem.1881","article-title":"Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells","volume":"33","author":"Franquesa","year":"2015","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.intimp.2024.113816_b0305","article-title":"CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.113816_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0667-7","article-title":"Metabolic determinants of the immune modulatory function of neural stem cells","volume":"13","author":"Drago","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2024.113816_b0315","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jneuroim.2016.12.005","article-title":"Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis","volume":"331","author":"Volpe","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113816_b0320","article-title":"Traumatic brain injury and stem cell: pathophysiology and update on recent treatment modalities","volume":"2017","author":"Reis","year":"2017","journal-title":"Stem Cells Int."},{"issue":"4","key":"10.1016\/j.intimp.2024.113816_b0325","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/neu.2008.0686","article-title":"The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat","volume":"26","author":"Rhodes","year":"2009","journal-title":"J. Neurotrauma"},{"issue":"7","key":"10.1016\/j.intimp.2024.113816_b0330","first-page":"12649","article-title":"Intravenous adipose-derived stem cells transplantation ameliorates memory impairment in moderate traumatic brain injury rats via the phosphorylation of extracellular signal-regulated kinase 1\/2","volume":"9","author":"Wu","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"7","key":"10.1016\/j.intimp.2024.113816_b0335","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/0960327113509659","article-title":"Paracrine factors of human mesenchymal stem cells increase wound closure and reduce reactive oxygen species production in a traumatic brain injury in vitro model","volume":"33","author":"Torrente","year":"2014","journal-title":"Hum. Exp. Toxicol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113816_b0340","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s12031-019-01475-w","article-title":"Can mesenchymal stem cells act multipotential in traumatic brain injury?","volume":"70","author":"Dehghanian","year":"2020","journal-title":"J. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.intimp.2024.113816_b0345","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/pharmaceutics14051112","article-title":"Heterogeneity of in vitro expanded mesenchymal stromal cells and strategies to improve their therapeutic actions","volume":"14","author":"Olmedo-Moreno","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.intimp.2024.113816_b0350","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcyt.2021.11.009","article-title":"Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion","volume":"24","author":"Srinivasan","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.intimp.2024.113816_b0355","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.toxrep.2021.11.016","article-title":"Non-clinical assessment of safety, biodistribution and tumorigenicity of human mesenchymal stromal cells","volume":"8","author":"Th\u00e4te","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.intimp.2024.113816_b0360","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1007\/s12035-017-0771-4","article-title":"Conditioned medium of human adipose mesenchymal stem cells increases wound closure and protects human astrocytes following scratch assay in vitro","volume":"55","author":"Baez-Jurado","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2024.113816_b0365","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s12035-017-0481-y","article-title":"Blockade of neuroglobin reduces protection of conditioned medium from human mesenchymal stem cells in human astrocyte model (T98G) under a scratch assay","volume":"55","author":"Baez-Jurado","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2024.113816_b0370","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1007\/s12035-018-1442-9","article-title":"Mitochondrial neuroglobin is necessary for protection induced by conditioned medium from human adipose-derived mesenchymal stem cells in astrocytic cells subjected to scratch and metabolic injury","volume":"56","author":"Baez-Jurado","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2024.113816_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-10-106","article-title":"Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury","volume":"10","author":"Zhang","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.intimp.2024.113816_b0380","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/scd.2019.0173","article-title":"Intravenously infusing the secretome of adipose-derived mesenchymal stem cells ameliorates neuroinflammation and neurological functioning after traumatic brain injury","volume":"29","author":"Xu","year":"2020","journal-title":"Stem Cells Dev."},{"issue":"3","key":"10.1016\/j.intimp.2024.113816_b0385","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/stem.2509","article-title":"Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression","volume":"35","author":"Davies","year":"2017","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.intimp.2024.113816_b0390","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12974-022-02398-x","article-title":"PD-L1 signaling in reactive astrocytes counteracts neuroinflammation and ameliorates neuronal damage after traumatic brain injury","volume":"19","author":"Gao","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.intimp.2024.113816_b0395","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcyt.2020.12.009","article-title":"Pre-clinical investigation of mesenchymal stromal cell-derived extracellular vesicles: a systematic review","volume":"23","author":"Shekari","year":"2021","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1016\/j.intimp.2024.113816_b0400","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1111\/cns.14159","article-title":"Human umbilical cord mesenchymal stem cell\u2010derived exosome suppresses programmed cell death in traumatic brain injury via PINK1\/Parkin\u2010mediated mitophagy","volume":"29","author":"Zhang","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"18","key":"10.1016\/j.intimp.2024.113816_b0405","doi-asserted-by":"crossref","first-page":"18274","DOI":"10.18632\/aging.103692","article-title":"MSC-derived exosomes promote recovery from traumatic brain injury via microglia\/macrophages in rat","volume":"12","author":"Chen","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.intimp.2024.113816_b0410","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3171\/2014.11.JNS14770","article-title":"Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury","volume":"122","author":"Zhang","year":"2015","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.intimp.2024.113816_b0415","article-title":"Protective effect of BMSCs-derived exosomes mediated by BDNF on TBI via miR-216a-5p","volume":"26","author":"Xu","year":"2020","journal-title":"Med. Sci. Monit."},{"issue":"11","key":"10.1016\/j.intimp.2024.113816_b0420","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1089\/neu.2020.7575","article-title":"MiR-17\u201392 cluster-enriched exosomes derived from human bone marrow mesenchymal stromal cells improve tissue and functional recovery in rats after traumatic brain injury","volume":"38","author":"Zhang","year":"2021","journal-title":"J. Neurotrauma"},{"issue":"9","key":"10.1016\/j.intimp.2024.113816_b0425","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3390\/life13091924","article-title":"The role of microglial exosomes and miR-124-3p in neuroinflammation and neuronal repair after traumatic brain injury","volume":"13","author":"Mavroudis","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.intimp.2024.113816_b0430","doi-asserted-by":"crossref","unstructured":"Hsieh, J., et al., Mesenchymal Stem Cells from Human Umbilical Cord Express Preferentially. 2013.","DOI":"10.1371\/journal.pone.0072604"},{"issue":"1","key":"10.1016\/j.intimp.2024.113816_b0435","article-title":"Reprogramming stem cells in regenerative medicine","volume":"1","author":"Mao","year":"2022","journal-title":"Smart Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113816_b0440","article-title":"Stem cells for organoids","volume":"1","author":"Qian","year":"2022","journal-title":"Smart Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.113816_b0445","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s12015-022-10369-1","article-title":"A brief overview of global trends in MSC-based cell therapy","volume":"18","author":"Jovic","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2024.113816_b0450","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.intimp.2024.113816_b0455","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1093\/brain\/awaa333","article-title":"Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis","volume":"143","author":"Petrou","year":"2020","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.intimp.2024.113816_b0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136133","article-title":"Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin column-based method","volume":"10","author":"Enderle","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.113816_b0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-01696-6","article-title":"The quality evaluation system establishment of mesenchymal stromal cells for cell-based therapy products","volume":"11","author":"Xie","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.intimp.2024.113816_b0470","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/med.21659","article-title":"An overview of international regulatory frameworks for mesenchymal stromal cell\u2010based medicinal products: from laboratory to patient","volume":"40","author":"L\u00f3pez-Beas","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.intimp.2024.113816_b0475","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.reth.2020.10.004","article-title":"Gaps between Asian regulations for eligibility of human mesenchymal stromal cells as starting materials of cell therapy products and comparability of mesenchymal stromal cell-based products subject to changes in their manufacturing process","volume":"15","author":"Tanaka","year":"2020","journal-title":"Regenerative Therapy"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:48:59Z","timestamp":1736614139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924023385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":95,"alternative-id":["S1567576924023385"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113816","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traumatic brain Injury: Comprehensive overview from pathophysiology to Mesenchymal stem Cell-Based therapies","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113816"}}